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Table 1. Diagnostic criteria for depressive disorder according to the ICD-10 
A. General criteria 
1. The depressive episode should last for at least 2 weeks 
2. There have been no hypomanic of manic symptoms sufficient to meet the criteria 
for hypomanic or manic episode at any time in the individuals life 
3. The episode is not attributable to psychoactive substance use or to any organic 
mental disorder   
B. At least two of the following three symptoms must be present 
1.  Depressed mood to a degree that is definitely abnormal for the individual, present 
for most of the day and almost every day, largely uninfluenced by circumstances, 
and sustained for at least 2 weeks. 
2. Loss of interest or pleasure in activities that are normally pleasurable 
3. Decreased energy or increased fatiguability 
C. An additional symptom or symptoms from the following list should be present, to give a 
total of at least four: 
1. Loss of confidence and self-esteem 
2. Unreasonable feelings of self-reproach or excessive and inappropriate guilt 
3. Recurrent thoughts of death or suicide, or any suicidal behavior 
4. Complaints or evidence of diminished ability to think or concentrate, such as 
indecisiveness or vacillation 
5. Change in psychomotor activity, with agitation or retardation (either subjective or 
objective) 
6. Sleep disturbance of any type 
7. Change in appetite (decrease or increase) with corresponding weight change 
The depressive episode classified by degree: 
- Mild. A total of at least four symptoms 
- Moderate. Ta total of at least six symptoms 
- Severe. All symptoms in B must be present and at least five symptoms from C must be 
present, to give a total of at least eight. 
a) Severe depressive episode without psychotic symptoms: no delusions, hallucinations 
or depressive stupor 
b) Severe depressive episode with psychotic symptoms: presence of delusions or 





Table 2. Diagnostic criteria for major depressive episode according to the DSM-IV-TR
A. Five or more of the following symptoms have been present during the previous 2-week 
period and represent a change from previous functioning; at least one of the symptoms 
is either 1) depressed mood or 2) loss of interest or pleasure.  
1) Depressed mood most of the day, nearly every day, as indicated by either subjective 
report (e.g. feels sad or empty) or observation made by others (e.g. appears tearful) 
2) Markedly diminished interest and pleasure in all, or almost all, activities most of the 
day, nearly every day (as indicated by either subjective account or observation made 
by others) 
3) Significant weight loss when not dieting or weight gain (e.g. a change of more than 
5% of body weight in a month), or decrease or increase in appetite nearly every day  
4) Insomnia or hypersomnia nearly every day 
5) Psychomotor agitation or retardation nearly every day (observable by others, not 
merely subjective feelings of restlessness or being slowed down) 
6) Fatigue or loss of energy nearly every day 
7) Feelings of worthlessness or excessive or inappropriate guilt (which may be 
delusional) nearly every day (not merely self-reproach or guilt about being sick) 
8) Diminished ability to think or concentrate, or indecisiveness, nearly every day (either 
by subjective account or as observed by others) 
9) Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation 
without a specific plan of committing suicide  
B. The symptoms do not meet criteria for mixed episode 
C. The symptoms cause clinically significant distress or impairment in social, occupational or 
other important areas of functioning  
D. The symptoms are not due to direct psychological effects of a substance (e.g. a drug 
abuse, a medication) or a general medical condition (e.g. hypothyroidism) 
E. The symptoms are not better accounted for by bereavement (i.e. after the loss of a loved 
one), the symptoms persist for longer than 2 months or are characterized by marked 
functional impairment, morbid preoccupation with worthlessness, suicidal ideation, 
























































































































































• Age-related brain changes
• Disease-related changes-eg, 
arteriosclerosis, inflammatory, 
endocrine, and immune changes
• Allostatic response to adversity
Vulnerability
• Abnormalities in frontostriatal





Mechanisms mediating depressed 
states
Hypometabolism of dorsal 
neocortical structures




























































































1.2 Cognitive impairment 



























































































Textbox 1. MCI criteria according to Mayo and Winblad 
The original Mayo criteria 
 
x Memory complaint, preferably 
corroborated by an informant  
x Objective memory impairment for age 
x Relatively preserved general cognition for 
age 
x Essentially intact activities of daily living 




The Winblad criteria 
 
x Not normal, not demented (Does not meet 
criteria for a dementia syndrome 
x Cognitive decline 
o Self and/or informant report and 
impairment on objective cognitive 
tasks and/or 
o Evidence of decline over time on 
objective cognitive tasks 
x Preserved basic activities of daily living / 
minimal impairment in complex instrumental 
functions  
 
Types of MCI 
x Amnestic MCI 
x Multiple domain MCI 
x Single nonmemory domain 
 
 
Types of MCI 
x Amnestic MCI 
x Amnestic multidomain MCI 
x Single nonmemory MCI 





































































































Table 3. Research criteria for dementia according to the ICD-10 
I. A decline in memory, especially for new information, objectively verified. 
II. A decline in other cognitive abilities as judgment, thinking, planning, organizing                   
and abstraction.  
- Mild. The decline influence on the activities of daily living. 
- Moderate. The decline makes it impossible to function without help. 
- Severe. The decline makes continuously help required 
III. Preserved awareness of the environment 
IV. A decline in emotional control, motivation or a change in social behavior 
- Emotional lability 
- Irritability 
- Apathy 
- Coarsening of social behavior 







Table 4. Dementia according to the DSM-IV criteria 
A. Development of multiple cognitive impairments: 
A1. Memory impairment 
A2. Impairment in at least one other cognitive disturbances: a )aphasia b) apraxia, c) agnosia, d) 
disturbance in executive functions 
B. The cognitive deficits in criteria A1 and A2 must  
1.  cause significant impairment in social or occupational functioning, and  
2.  represent a decline from a previous level of functioning  
C.  The dementia diagnosis should not be made if the symptoms occur exclusively during the course of 
delirium  















Table 5. Mild and major neurocognitive disorders according to the DSM-5 
A. Evidence of significant cognitive decline from a previous level of performance in one or 
more cognitive domains (complex attention, executive function, learning and memory, 
language, perceptual-motor, or social cognition) based on: 
1. Concern of a significant decline in cognitive function, and 
2. A documented substantial (major NCD) or modest (mild NCD) impairment in 
cognitive performance  
B. Interfere with the independence in everyday activities. 
C. The cognitive decline does not occur exclusively in the context of delirium. 























































































Figure 3. Hypothetical model of AD pathophysiological cascade$GMXVWHGIURP6SHUOLQJ
HWDO





















Other age-related brain diseases









































































































































































































































































































































































1.5 Depression and dementia 




























































































































Table 6. Provisional diagnostic criteria for depression of Alzheimer Disease
A. Three or more of the following symptoms have been present during the same 2-week 
period and represent a change from previous functioning: at least one of the symptoms 
is either 1) depressed mood or 2) decreased positive affect or pleasure. 
1) Clinically significant depressed mood (e.g. depressed, sad, hopeless, discouraged, 
tearful) 
2) Decreased positive affect of pleasure in response to social contacts or usual activities 
3) Social isolation or withdrawal 
4) Disruption of appetite 
5) Disruption to sleep 
6) Psychomotor changes (e.g. agitation or retardation) 
7) Irritability 
8) Fatigue or loss of energy 
9) Feelings of worthlessness, hopelessness or excessive or inappropriate guilt 
10) Recurrent thoughts of death, suicidal ideas, plan or attempt 
B. All criteria are met for Dementia of the Alzheimer type (DSM-IV-TR) 
C. The symptoms cause clinically significant distress or disruption in functioning 
D. The  symptoms do not occur exclusively during the course of delirium 
E. The Symptoms are not due to the direct physiological effect of a substance (e.g. drug of 
abuse or a medication 
F. The symptoms are not better accounted for by other conditions such as major depressive 
disorders, bipolar disorder, bereavement, schizophrenia, schizoaffective disorder, 








































































































































































































































1.7 Psychometric characteristics of tests and 





















































































Table 7. The relationship between a test and a disease$[WDEOHRIWKHSRVVLEOH
UHVXOWVDGIURPFRPSDULQJDGLDJQRVWLFWHVWWREHYDOLGDWHGDQGDUHIHUHQFHVWDQGDUG
  Reference standard   
Test Disease present Disease absent Sum 
Test positive a (true positive) b (false positive) a + b  
Test negative  c (false negative) d (true negative) c + d  




Table 8. Properties of a diagnostic test 
Sensitivity: a/(a+c) 
Specificity: d/(b+d) 
Prevalence of the diagnosis in the study population: (a+c) / (a+b+c+d) 
Positive predictive value (PPV): a / (a+b) 
Negative predictive value (NPV): d / (c+d) 
Accuracy: (a+d) / (a+b+c+d) 
Positive likelihood ratio (LR+): sensitivity / (1-specificity) 


























































































































Table 9.The table shows the number and main characteristics of the patients included in 
sub-studies I to IV 
  Validity study (I) 




Number of patients 125 1470 520 211 
Site of inclusion 
    
Oslo University Hospital 97 510 361 125 
Innlandet Hospital Trust (SI) 28 298 159 
 
Other outpatient clinics 662 
 
Rio de Janeiro   86 
Age (SD) 67.4 (9.2) 73.3 (11.0) 69.3 (10.9) 70.2 (9.2)  
Women (%) 61 (48.8) 804 (54.7) 293 (56.3) 124 (58.8)  
SCI, n (%) 29 (23.2) 203 (13.8) 110 (21.2)  38 (18.0)  
MCI, n (%) 41 (32.8) 517 (35.2) 169 (32.5)   57 (26.9)  




























Figure 5. Procedure for the dementia assessment at the Memory Clinics$GMXVWHGIURP
%UDHNKXVHWDO
006(15 1RUZHJLDQUHYLVLRQRI0LQL0HQWDO6WDWXV([DPLQDWLRQ707$DQG% 7UDLO0DNLQJ7HVW$DQG%0$'56
 0RQWJRPHU\$DVEHUJ'HSUHVVLRQ5DWLQJ6FDOH,4&2'( ,QIRUPDQW4XHVWLRQQDLUHIRU&RJQLWLYH'HFOLQH$'/ 









First consultation 2-3 hours
Physician, nurse, patient and 
caregiver
Registration
Information about the assessment
Nurse and caregiver
• Informant questionnaire for 
cognitive decline (IQCODE)
• Medical history given by family
• Assessment of ADL failure
⁻ Clinical interview
⁻ P-ADL and I-ADL  scales 
• Assessment of BPSD




⁻ Relative Stress Scale (RSS)
Physician  and patient
• Cognitive function
⁻ Clinical interview
⁻ Cognitive tests (MMSE-NR, clock 
drawing  test, ten-word test, TMT 
A+B, figures drawing test, 







• Samples of blood and spinal fluid
• MRI cerebrum
• SPECT or PET if appropriate
• Neuropsychologist if appropriate
• Evaluation of practical driving skills 
by Driver and Vehicle Licensing 
Agency if appropriate
Consensus
Second consultation – physician, nurse, patient and family
Summary – diagnosis, treatment or referral to other specialists, 
































































































Table 10. Statistical methods used in the four sub-studies 
Sub-study Statistical methods 
Validity study (I) Receiver operation characteristics (ROC 
analyses) with area under the curve (AUC), 
accuracy, sensitivity, specificity, and likelihood 
ratios for positive and negative tests 
Prevalence study (II) Chi square analyses, correlation, and logistic 
regression analyses 
Correlation study (III) Correlation and principal component analyses 
Cross-cultural study (IV) Correlation and multiple linear regression 
analyses 
















2.7 Results from the papers – the abstracts and 
additional information 










































































OUS + SI 
(n=808) 
The other 
 clinics (662) P value 
Patient characteristics       
Mean age (n=1461) 72.5 10.8 68.6 (10.8) 77.3 (8.7) <0.001c 
Females  804 55.0 406 (50.5) 398 (60.5) <0.001a 
Married 935 63.6 576 (71.3) 359 (54.2) <0.001a 
Education (n=1380) 11.2 3.7 11.9 (3.9) 10.2 (3.2) <0.001c 
I-ADL (n=1398) (8-32) 13.5 5.3 12.1 (4.5) 15.2 (5.7) <0.001b 
P-ADL (n=1380) (6-30) 7.6 2.6 7.0 (2.1) 8.4 (3.1) <0.001b 
Comorbidity  1160 78.9 654 (80.9) 556 (84.0) 0.26a 
Cerebrovascular diseases 343 23.3 168 (20.8) 175 (26.4) 0.07 
Neurological diseases 290 19.7 195 (24.1) 96 (14.5) <0.001 
Cardiovascular diseases 792 53.9 389 (48.1) 403 (60.9) 0.001 
Endocrine diseases 523 35.6 297 (36.8) 226 (34.1) 0.21 
Cognition and dementia 
MMSE score (n=1450) 23.8 4.7 24.9 (4.1) 22.4 (4.9) <0.001b 
CDT score (n=1419) 3.5 1.6 3.7 (1.5) 3.2 (1.6) < 0.001b 
Diagnoses (n=1470) < 0.001
a 
 SCI 203 13.8 174 (21.5) 29(4.4) 
  MCI 517 35.2 277 (34.3) 240 (36.3) 
  AD 433 29.5 164 (20.3) 269 (40.6) 
  VaD 52 3.5 10 (1.2) 42 (6.3) 
  AD/VaD 77 5.2 43 (5.3) 34 (5.1) 
  DLB/Parkinson 36 2.4 26 (3.2) 10 (1.5) 
  FTD 12 0.8 10 (1.2) 2 (0.3) 
  Unspecified dementia 140 9.5 104 (12.9) 36 (5.4) 
Dementia  750 51.0 357 (44.2) 393 (59.4) <0.001a 
Depression 
Cornell, score (n=1470) 6.7 5.3 6.5 (5) 6.9 (5.7) 0.71b 
Previous depression 289 19.7 186 (23) 103 (15.6) <0.001a 
Use of antidepressants 232 15.7 125 (15.5) 107 (16.2) 0.39a 
a= X2 (Chi square) test, b = Mann-Whitney test, c = t –test, P-ADL = personal activities of daily living, I-ADL = 
instrumental activities of daily living, MMSE = mini mental state examination, CDT = Clock Drawing Test, SCI = 
subjective cognitive impairment, MCI = mild cognitive impairment, AD = Alzheimer’s disease, VaD = vascular 
dementia, DLB = Dementia with Lewy Bodies, FTD = frontotemporal dementia  

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Table 12. Spearman’s correlations between the CSDD and the MADRS scores for sub-
sample, separated for the two clinics at Oslo University Hospital and Innlandet Hospital 
Trust
  Total sum scores Oslo University Hospital (OUS) 
Innlandet Hospital 
Trust (SI) 
All patients (n=520) 0.36 0.27 0.58 
Women (56.3%) 0.31 0.20 0.59 
Men (43.7%) 0.41 0.36 0.51 
Age (n=520) 
40-64 (31.7%) 0.31 0.21 0.48 
65-75 (36.2%) 0.37 0.33 0.43 
76-93 (32.1%) 0.46 0.31 0.79 
Years of education (n=506) 
<=8 (30.2%) 0.40 0.23 0.64 
>=9 (69.8%) 0.38 0.32 0.55 
Marital status (n=510) 
Married (67.8%) 0.43 0.37 0.58 
Not married (32.5%) 0.25 0.14 0.59 
Diagnosis  
SCI (21.2 %) 0.49 0.38 0.63 
MCI (32.5%) 0.47 0.40 0.61 
Dementia (46.3% ) 0.22 0.16 0.47 
MMSE score (n=517) 
3-21 (21.9%) 0.25 0.14 0.55 
22-25 (26.5%) 0.35 0.22 0.53 
26-28 (29.5%) 0.45 0.41 0.62 
29-30 (22.1%) 0.38 0.29 0.62 
Clock Drawing Test (n=427) 
Approved 0.41 0.33 0.59 
Not approved 0.38 0.24 0.56 
Caregiver (n=510) 
Spouse (67.8%) 0.43 0.37 0.55 
Others (32.2%) 0.27 0.12 0.64 
Relative Stress Scale (RSS) (n=494) 
RSS score below 10 (50.4%) 0.39 0.31 0.56 
RSS score above 9 (49.6%) 0.30 0.19 0.64 
SCI = subjective cognitive impairment, MCI = mild cognitive impairment, MMSE = Mini Mental State Examination  

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Figure 6. The severity of the various symptoms of depression according to the CSDD in
patients with depression in Brazil and Norway (mean values).7KH SEHWZHHQWKHWZR
JURXSV

Figure 7. The severity of the various 
symptoms of depression according to 
the MADRS in the patients with 
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